C O M M U N I C A T I O N S
(1.5:1) in a combined yield of 64%.16 Deprotection of 23 (Na in
NH3, THF, and t-BuOH warming from -78 to -45 °C) afforded
(()-strychnofoline (1) in 82% yield (Scheme 7). The synthetic
material isolated was in all respects identical to the material from
natural sources by TLC, mass spectrometry, 13C NMR, and 1H NMR
spectroscopy.
Scheme 5
In summary, we have reported an efficient synthesis of the
antitumor alkaloid (()-strychnofoline. Key to the development of
the highly convergent strategy delineated is the coupling of a cyclic
imine with spiro[cyclopropan-1,3′-oxindole], which takes place in
a highly diastereoselective manner. Additional studies on mecha-
nistic and preparative aspects of this reaction are underway and
will be reported as results are forthcoming.
Scheme 6 a
Acknowledgment. This work is dedicated to Professor Scott
E. Denmark. We are grateful to Prof. Luc Angenot for his assistance
in comparing the synthesized and natural products, Dr. B. Schweizer
for X-ray analysis, and Prof. B. Jaun for NMR studies. Support
has been provided by the ETH.
a (a) NMO, OsO4, H2O, dioxane, t-BuOH, room temperature. (b) NaIO4,
H2O, t-BuOH, dioxane, room temperature. (c) p-TsOH, MeOH, CH(OMe)3,
room temperature. (d) TBAF, THF, room temperature. (e) IBX, DMSO,
room temperature. (f) t-BuOK, Ph3PMeBr, THF, room temperature. (g) 10%
aqueous HCl, acetone, room temperature.
Supporting Information Available: Experimental procedures,
spectral data, and structure correlation for all relevant compounds (PDF).
This material is available free of charge via the Internet at http://
pubs.acs.org.
Scheme 7 a
References
(1) Angenot, L. Plant Med. Phytother. 1978, 12(2), 123-129.
(2) Bassleer, R.; Depauw-Gillet, M. C.; Massart, B.; Marnette, J.-M.; Wiliquet,
P.; Caprasse, M.; Angenot, L. Planta Med. 1982, 45, 123-126.
(3) Cui, C.-B.; Kakeya, H.; Osada, H. J. Antibiot. 1996, 49, 832-835.
(4) Alper, P. B.; Meyers, C.; Lerchner, A.; Siegel, D. R.; Carreira, E. M.
Angew. Chem., Int. Ed. 1999, 38, 3186-3189.
(5) Fischer, C.; Meyers, C.; Carreira, E. M. HelV. Chim. Acta 2000, 83, 1175-
1181.
(6) (a) Hendrickson, J. B.; Silva, R. A. J. Am. Chem. Soc. 1962, 84, 3-650.
(b) Ban, Y.; Oishi, T. Chem. Pharm. Bull. Jpn. 1963, 11, 451-460. (c)
van Tamelen, E. E.; Yardley, J. P.; Miyano, M.; Hinshaw, W. B., Jr. J.
Am. Chem. Soc. 1969, 91, 7333-7341. (d) Brown, R. T.; Chapple, C. L.;
Platt, R. Tetrahedron Lett. 1976, 17, 1401-1402. (e) Rosenmund, P.;
Hosseini-Merescht, M.; Bub, C. Liebigs Ann. Chem. 1994, 151-158. (f)
Shavel, J., Jr.; Zinnes, H. J. Am. Chem. Soc. 1962, 84, 1320-1321. (g)
Finch, N.; Taylor, W. I. J. Am. Chem. Soc. 1962, 84, 1318-1320.
(7) Carroll, W. A.; Grieco, P. A. J. Am. Chem. Soc. 1993, 115, 1164-1165.
(8) The synthesis of 12 commences with 1,4,5,6-tetrahydro-6-oxo-1-(phenyl-
methyl)-3-pyridinecarboxylic acid methyl ester, whose synthesis in two
steps is reported: Cook, G. R.; Beholz, L. G.; Stille, R. G. J. Org. Chem.
1994, 59, 3575-3584. Reduction of the ester with LiBH4 to the alcohol,
deprotection of the benzyl moiety with Na in NH3, protection of the
hydroxyl-moiety with TBDPSCl, and protection of the amide with Boc2O
afforded 12.
a (a) N-Methyltryptamine, AcOH, toluene, 80 °C. (b) Na, NH3, THF,
t-BuOH, -78 to -45 °C.
two newly formed stereocenters at C-3 and C-7 was confirmed by
1H NMR NOE studies and ultimately through X-ray crystallographic
analysis of 20 (vide infra).12 Although the underlying stereodeter-
mining elements leading to the formation of 18 are difficult to
discern at present, the stereochemical outcome is congruent with
the known preferences in related alkaloids such as rhynchophylline
and isorhynchophylline.13 For these, the observed stereochemistry
has been suggested to result from thermodynamic considerations.
In this regard, analysis of diastereomers epimeric at C-3 reveals
that destabilizing axial interactions would be unavoidable, and
diastereomers epimeric at C-7 are suggested to be precluded because
of ensuing unfavorable interactions between the nitrogen and
carbonyl lone pairs.
Elaboration of the key intermediate to the natural product
commenced with conversion of alkene 18 to ketal 19 (Scheme 6).
Thus, oxidative cleavage of 18 (OsO4, NaIO4) furnished the
corresponding aldehyde, which was protected (CH(OMe)3 and
p-TsOH, MeOH) to afford dimethoxyacetal 19 (80%, over three
steps). Desilylation with TBAF, followed by an oxidation with IBX
in DMSO and Wittig olefination, provided 20 in 66% overall yield
(three steps).14 Deprotection of the acetal with aqueous HCl in
acetone provided aldehyde 21 (94%). Completion of the natural
product necessitated coupling the N-methyl carboline side chain.
In this respect, Pictet Spengler reaction15 of aldehyde 21 and
N-methyl-tryptamine using AcOH in toluene at 80 °C afforded a
diastereomeric mixture of products 22 and desired 23 nonselectively
(9) Herdeis, C.; Hubmann, H. P. Tetrahedron: Asymmetry 1992, 3, 1213-
1221.
(10) The facile conversion of the lactamol into the enamine was surprising,
considering that other less substituted lactamols were converted into the
corresponding enamine only upon heating to 160 °C in HMPA for several
hours: Dieter, R. K.; Sharma, R. R. J. Org. Chem. 1996, 61, 4180-
4184.
(11) The synthesis of 17 commences with 6-methoxyisatine which is com-
mercially available, see Supporting Information.
(12) Particularly useful was an observed NOE between the aromatic C-9 proton
and the appropriate Hâ at C-14.
(13) For an in-depth discussion, see: Brown, R. T. In Heterocyclic Compounds;
Saxon, J. E., Ed.; Wiley-Interscience: New York, 1983; Vol. 25, Part 4,
pp 85-97.
(14) Compound 20 yielded suitable crystals for X-ray structure determination,
thus confirming the stereochemical assignments made earlier on the basis
of 1H NMR, see Supporting Information.
(15) Burm, B. E. A.; Meijler, M. M.; Korver, J.; Wanner, J. M.; Koomen, G.
Tetrahedron 1998, 54, 6135-6146.
(16) Although we did not anticipate stereoselectivity in this condensation
reaction of the simple tryptamine derivative, it is important to note that
stereoselective Pictet Spengler reactions have been documented employing
tryptophan derivatives. Application of such methods at this stage would
likely provide the desired product stereoselectively. (a) Watson, W. H.;
Krawiec, M. J.; Cox, E. D.; Hamaker, L. K.; Li, J.; Yu, P.; Czerwinski,
K. M.; Deng, L.; Bennet, D. W.; Cook, J. M. J. Org. Chem. 1997, 62,
44-61. (b) Waldmann, H.; Schmidt, G.; Jansen, M.; Geb, J. Tetrahedron
1994, 50, 11865-11884.
JA027906K
9
J. AM. CHEM. SOC. VOL. 124, NO. 50, 2002 14827